Search

everythinglearnresearchcommunity

for

Search:↓

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Desolvation of finasteride depends on environment and technique.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Improved finasteride formula allows slow, sustained release and better absorption for patients.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

This enzyme helps metabolize fatty acids and isoleucine, and could be key in treating neurological diseases and certain cancers.

Steroid hormones change the size, charge, and stability of DPPC liposomes.

Researchers made two new compounds that could be used for medicine.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Compound 15a was effective in inhibiting 5α-reductase.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Micelles can change cetirizine's ionization, affecting its effectiveness in treatments.